Schedule 13D ownership disclosure

Inmune Bio Inc

Security class unavailable · CUSIP: 45782T105

Event date: 2019-02-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001640334-19-000218
Form type
SC 13D
Filer
Inmune Bio, Inc.
CIK
CIK 1711754
Filed
Feb 11, 2019
Reporting period
Feb 01, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub